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ABSTRACT 
Dengue is a common infection, caused by dengue virus. There are four different dengue 
serotypes, with different capacity to cause severe dengue infections. Besides, secondary 
infections with heterologous serotypes, concurrent infections of multiple dengue serotypes 
may alter the severity of dengue infection. This study aims to compare the severity of single 
infection and concurrent infections of different combinations of dengue serotypes in-vitro. 
Human mast cells (HMC)-1.1 were infected with single and concurrent infections of multiple 
dengue serotypes. The infected HMC-1.1 supernatant was then added to human umbilical 
cord vascular endothelial cells (HUVEC) and severity of dengue infections was measured by 
the percentage of transendothelial electrical resistance (TEER). Levels of IL- 10, CXCL10 
and sTRAIL in HMC-1.1 and IL-8, IL-10 and CXCL10 in HUVEC culture supernatants were 
measured by the ELISA assays. The result showed that the percentage of TEER values were 
significantly lower in single infections (p< 0.05), compared to concurrent infections on day 2 
and 3, indicating that single infection increase endothelial permeability greater than 
concurrent infections. IL-8 showed moderate correlation with endothelial permeability (r 
>0.4), indicating that IL-8 may be suitable as an in-vitro severity biomarker. In conclusion, 
this in-vitro model presented few similarities with regards to the conditions in dengue 
patients, suggesting that it could serve as a severity model to test for severity and levels of 
severity biomarkers upon different dengue virus infections. 
